From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream 
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will...
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2025 American College of Rheumatology (ACR) Convergence
CHATHAM, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated,...
RadNet to Host Investor Day on November 11, 2025
LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic...
PrestoDoctor Expands Into Michigan Ahead of New Cannabis Tax Changes
Strategic market entry positions company for growth as Michigan prepares for 2026 tax reformsMesquite, NV, Oct. 21, 2025 (GLOBE NEWSWIRE)...
Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist with the potential to treat a wide range of...
Acies Bio doubling biomanufacturing capacity with the construction of 30 m³ bioreactor
KAMNIK, Slovenia, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Acies Bio has begun the project for construction of facility with expanded...
Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
Saint-Genis-Pouilly, France, 21 October 2025 – Step Pharma (“the Company”), the global leader in CTPS1 inhibition for targeted cancer treatment,...
Hear At Last Signs Exclusive Contract with Hebei Jiachen Integrated Housing Co. for Affordable Modular Homes in North and Central America as Well as the Caribbean
Miami, Florida--(Newsfile Corp. - October 21, 2025) - Hear At Last (OTCID: HRAL), a leader in innovative housing solutions, is...
TempraMed Announces Private Placement of up to C$2.5 Million
Vancouver, British Columbia--(Newsfile Corp. - October 21, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed" or the "Company") is pleased to announce...
Breakthrough Genomics Showcases Largest Interpreted Literature Database and Unveils New AI Capabilities at ASHG 2025
IRVINE, Calif., Oct. 21, 2025 /PRNewswire/ -- Breakthrough Genomics, a leader in AI-powered clinical genomics interpretation, today announced new research...
Astraveus further strengthens world class leadership team to advance development of Lakhesys Benchtop Cell Factory™
Highly experienced hires bring robust operational and technical expertise Momentum builds at Astraveus following exceptional additions of Jean-Paul Mangeolle, David...
Haut.AI Launches Ground Breaking GenAI Powered Skin Aging Simulation
Empowering People to See – and Change – Their Future Selves, with Noom as the First Partner NEW YORK, Oct. 21,...
Embla Medical hf: Interim Report Q3 2025
COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ -- Announcement no. 49/2025 Interim report Q3 2025 21 October 2025 Sveinn Sölvason, President...
Neutec Group Guides Buyers From Product Discovery to Product Validation With Bioz Badges
PALO ALTO, CA / ACCESS Newswire / October 21, 2025 / Bioz, Inc., a pioneering AI platform changing the way...
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
VANCOUVER, BC / ACCESS Newswire / October 21, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience...
Only 27% of European Hospitals Achieve Full Patient Data Exchange Across Borders Despite EU Interoperability Mandates
Black Book survey reveals just 1 in 4 hospitals can fully exchange patient data across national boundaries in Q4 2025...
Cosmo Pharmaceuticals Receives Regulatory Approval by the European Commission for Winlevi(R) in the EU, Following on the Positive CHMP Opinion
Dublin, Ireland--(Newsfile Corp. - October 21, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and...
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy
TAIPEI and SAN DIEGO, Oct. 20, 2025 /PRNewswire/ -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in...
Autism Therapy Group Brings its Center-Based Care Model to Kansas City Area with Opening of New Clinic in Shawnee
SHAWNEE, Kan., Oct. 20, 2025 /PRNewswire/ -- Caravel Autism Health, a leader in the diagnosis and treatment of young children...
CaseBioscience® Launches CaseBio™ Culture and CaseBio™ Handling Media at ASRM 2025 After FDA 510(k) Clearance and Clinical Evaluation
Reflecting years of stem cell research and innovation in assisted reproductive technology, CaseBioscience® advances ART through the science of stem...